Oana Health provides telehealth services to connect you with licensed professionals who specialize in hormonal health and PCOS treatments, including spironolactone prescriptions
Of those reporting no SGLT2i use at baseline, increasing numbers of participants started SGLT2i during the trial, with a greater proportion starting SGLT2i in the placebo (approximately 10% at 18 months and approximately 20% at 36 months) than in the semaglutide group (approximately 5% at 18 months and approximately 10% at 36 months
The potential of Ozempic to aid in weight management and reduce inflammation presents a promising avenue for research and treatment
Advanced analytics platforms enable companies to evaluate their existing product lines with unprecedented precision, identifying gaps where healthier alternatives or portion-controlled options could flourish
That presents serious safety concerns of its own
Regular monitoring should include: Weight and BMI measurements : Typically assessed monthly initially, then at least every three months
